kabutan

EIKEN CHEMICAL CO.,LTD.(4549) Summary

4549
TSE Prime
EIKEN CHEMICAL CO.,LTD.
2,400
JPY
-17
(-0.70%)
Jan 29, 3:30 pm JST
15.69
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
20.9
PBR
1.80
Yield
2.42%
Margin Trading Ratio
2.65
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
2,417 JPY 15.78 USD
Previous Close Jan 28
2,417 JPY 15.83 USD
High Jan 29, 9:00 am
2,442 JPY 15.95 USD
Low Jan 29, 9:06 am
2,372 JPY 15.49 USD
Volume
78,600
Trading Value
0.19B JPY 1.23M USD
VWAP
2399.97 JPY 15.69 USD
Minimum Trading Value
240,000 JPY 1,569 USD
Market Cap
0.08T JPY 0.55B USD
Number of Trades
344
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
395
1-Year High Aug 1, 2025
1,407
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 51,300 108,800 2.12
Jan 16, 2026 47,900 96,600 2.02
Jan 9, 2026 40,500 83,900 2.07
Dec 26, 2025 41,100 75,500 1.84
Dec 19, 2025 38,100 66,900 1.76
Company Profile
EIKEN CHEMICAL CO.,LTD. is a leading manufacturer of clinical diagnostic reagents, with a high market share in fecal occult blood test reagents. The company also produces reagents for microbiology, genetic testing, and urinalysis.
Sector
Pharmaceuticals
EIKEN CHEMICAL CO.,LTD. specializes in the manufacture and sale of clinical diagnostic reagents as its core business. The company holds the top domestic market share in fecal occult blood test reagents. It operates both domestically and internationally, with a consolidated subsidiary in China called Eiken China Co., Ltd. This Chinese subsidiary engages in contract manufacturing of the company's diagnostic reagents and the purchase, manufacture, and sale of diagnostic products. The group as a whole focuses on the diagnostic reagent business, maintaining a strong position in the domestic market while expanding overseas. International sales account for approximately one-quarter of the company's total revenue. EIKEN CHEMICAL CO.,LTD. contributes to improving the quality of healthcare by leveraging its technological expertise and product development capabilities in the field of clinical diagnostic reagents.